| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
4,038 |
3,592 |
$1.96M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
9,694 |
8,358 |
$391K |
| 92134 |
|
18,830 |
16,814 |
$178K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,587 |
3,545 |
$174K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
395 |
314 |
$144K |
| J9035 |
Injection, bevacizumab, 10 mg |
4,276 |
3,629 |
$112K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,159 |
1,150 |
$73K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,957 |
2,887 |
$55K |
| 76512 |
|
2,571 |
2,266 |
$55K |
| 67210 |
|
193 |
155 |
$44K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,448 |
2,267 |
$33K |
| 92201 |
|
4,023 |
3,840 |
$32K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
801 |
763 |
$22K |
| 92226 |
|
2,676 |
2,413 |
$19K |
| 92235 |
|
385 |
366 |
$18K |
| 92273 |
|
282 |
277 |
$15K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
441 |
416 |
$14K |
| 92202 |
|
4,480 |
4,322 |
$12K |
| 92242 |
|
488 |
462 |
$9K |
| 92225 |
|
440 |
379 |
$4K |
| 92250 |
|
97 |
95 |
$2K |